New therapeutic frontiers for metabotropic glutamate receptors

Current Topics in Medicinal Chemistry

Volumn 5, Issue 9, 2005, Pages 847-857

  Niswender, Colleen M ^a   Jones, Carrie K ^a   Conn, P Jeffrey ^a  

^a VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Allosteric potentiator; Metabotropic glutamate receptor; mGlu receptor

Indexed keywords

(4' CYANO BIPHENYL 3 YL)(3 PYRIDINYLMETHYL)ETHANESULFONAMIDE; 2 AMINO 2 (2 CARBOXYCYCLOPROPYL) 3 (XANTHEN 9 YL)PROPIONIC ACID; 2 AMINO 4 PHOSPHONOBUTYRIC ACID; 2 METHYL 6 (2 PHENYLVINYL)PYRIDINE; 2 METHYL 6 (PHENYLETHYNYL)PYRIDINE; 2,2,2 TRIFLUORO[3(2 METHOXYPHENOXY)PHENYL](3 PYRIDINYLMETHYL)ETHANESULFONAMIDE; 3 [(2 METHYL 4 THIAZOLYL)ETHYNYL]PYRIDINE; 3 CYANO(1,3 DIPHENYL 1H PYRAZOL 5 YL)BENZAMIDE; 3,3' DICHLOROBENZALDAZINE; 3,3' DIFLUOROBENZALDAZINE; 4 AMINO 2 OXABICYCLO[3.1.0]HEXANE 4,6 DICARBOXYLIC ACID; 4 AMINOBUTYRIC ACID A RECEPTOR; 6 METHYL 2 PHENYLAZO 3 PYRIDINOL; 7 (HYDROXYIMINO)CYCLOPROPA(B)CHROMEN 1A CARBOXYLIC ACID ETHYL ESTER; [4 (CARBOXAMIDOPHENOXYL)PHENYL](3 PYRIDINYLMETHYL)ETHANESULFONAMIDE; [4 CHLORO 2 [(1,3 DIOXO 1,3 DIHYDRO 2H ISOINDOL 2 YL)METHYL]PHENYL] 2 HYDROXYBENZAMIDE; BENZODIAZEPINE DERIVATIVE; EGLUMETAD; METABOTROPIC RECEPTOR; METABOTROPIC RECEPTOR 1; METABOTROPIC RECEPTOR 2; METABOTROPIC RECEPTOR 3; METABOTROPIC RECEPTOR 4; METABOTROPIC RECEPTOR AGONIST; METABOTROPIC RECEPTOR ANTAGONIST; PHENYL 7 (HYDROXYIMINO)CYCLOPROPA 1A CARBOXMIDE; RO 01 6128; RO 67 4853; RO 67 7476; UNCLASSIFIED DRUG; UNINDEXED DRUG;

ALLOSTERISM; ALTERNATIVE RNA SPLICING; ANALGESIC ACTIVITY; ANXIETY DISORDER; BINDING AFFINITY; BINDING SITE; CLINICAL TRIAL; DEPRESSION; DRUG IDENTIFICATION; DRUG RECEPTOR BINDING; DRUG SCREENING; DRUG TARGETING; DRUG TOLERANCE; HUMAN; KNOCKOUT GENE; MOLECULAR CLONING; NERVE EXCITABILITY; NEUROMODULATION; NONHUMAN; PANIC; PARKINSON DISEASE; PHENOTYPE; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; PROTEIN TARGETING; REVIEW; SCHIZOPHRENIA; STRUCTURE ACTIVITY RELATION; SYNAPTIC TRANSMISSION; TRANQUILIZING ACTIVITY; VALIDATION PROCESS;

ALLOSTERIC REGULATION; ANIMALS; CLONING, MOLECULAR; DRUG DESIGN; EXCITATORY AMINO ACID AGENTS; EXCITATORY AMINO ACID ANTAGONISTS; GENE EXPRESSION REGULATION; HUMANS; RECEPTORS, METABOTROPIC GLUTAMATE;

EID: 24644471456     PISSN: 15680266     EISSN: None     Source Type: Journal    
DOI: 10.2174/1568026054750254     Document Type: Review

References (130)

1. Watkins, J.C. L-Glutamate as a Central Neurotransmitter: Looking Back. Biochem. Soc. Trans. 2000, 28(4), 297-309.
2. White, W.F.; Nadler, J.V.; Cotman, C.W. The Effect of Acidic Amino Acid Antagonists on Synaptic Transmission in the Hippocampal Formation In Vitro. Brain. Res. 1979, 164, 177-194.
3. Koerner, J.F.; Cotman, C.W. Micromolar L-2-Amino-4-Phosphonobutyric Acid Selectively Inhibits Perforant Path Synapses from Lateral Entorhinal Cortex. Brain. Res. 1981, 216(1), 192-198.
4. Koerner, J.F.; Cotman, C.W. Response of Schaffer Collateral-Ca 1 Pyramidal Cell Synapses of the Hippocampus to Analogues of Acidic Amino Acids. Brain. Res. 1982, 251(1), 105-115.
5. Davies, J.; Watkins, J.C. Actions of D and L Forms of 2-Amino-5-Phosphonovalerate and 2-Amino-4-Phosphonobutyrate in the Cat Spinal Cord. Brain. Res. 1982, 235(2), 378-386.
6. Evans, R.H.; Francis, A.A.; Jones, A.W.; Smith, D.A.; Watkins, J.C. The Effects of a Series of Omega-Phosphonic Alpha-Carboxylic Amino Acids on Electrically Evoked and Excitant Amino Acid-Induced Responses in Isolated Spinal Cord Preparations. Br. J. Pharmacol. 1982, 75(1), 65-75.
7. Sladeczek, F.; Pin, J.P.; Recasens, M.; Bockaert, J.; Weiss, S. Glutamate Stimulates Inositol Phosphate Formation in Striatal Neurones. Nature. 1985, 317(6039), 717-719.
8. Nicoletti, F.; Wroblewski, J.T.; Novelli, A.; Alho, H.; Guidotti, A.; Costa, E. The Activation of Inositol Phospholipid Metabolism as a Signal-Transducing System for Excitatory Amino Acids in Primary Cultures of Cerebellar Granule Cells. J. Neurosci. 1986, 6(7), 1905-1911.
9. Nicoletti, F.; Meek, J.L.; Iadarola, M.J.; Chuang, D.M.; Roth, B.L.; Costa, E. Coupling of Inositol Phospholipid Metabolism with Excitatory Amino Acid Recognition Sites in Rat Hippocampus. J. Neurochem. 1986, 46(1), 40-46.
10. Sugiyama, H.; Ito, I.; Hirono, C. A New Type of Glutamate Receptor Linked to Inositol Phospholipid Metabolism. Nature 1987, 325(6104), 531-533.
11. Curry, K.; Peet, M.J.; Magnuson, D.S.; McLennan, H. Synthesis, Resolution, and Absolute Configuration of the Isomers of the Neuronal Excitant 1-Amino-1,3-Cyclopentanedicarboxylic Acid. J. Med. Chem. 1988, 31(4), 864-867.
12. Palmer, E.; Monaghan, D.T.; Cotman, C.W. Glutamate Receptors and Phosphoinositide Metabolism: Stimulation via Quisqualate Receptors Is Inhibited by N-Methyl-D-Aspartate Receptor Activation. Brain. Res. 1988, 464(2), 161-165.
13. Desai, M.A.; Conn, P.J. Selective Activation of Phosphoinositide Hydrolysis by a Rigid Analogue of Glutamate. Neurosci. Lett. 1990, 109(1-2), 157-162.
14. Desai, M.A.; Conn, P.J. Excitatory Effects of ACPD Receptor Activation in the Hippocampus Are Mediated by Direct Effects on Pyramidal Cells and Blockade of Synaptic Inhibition. J. Neurophysiol. 1991, 66(1), 40-52.
15. Charpak, S.; Gahwiler, B.H.; Do, K.Q.; Knopfel, T. Potassium Conductances in Hippocampal Neurons Blocked by Excitatory Amino-Acid Transmitters. Nature 1990, 347(6295), 765-767.
16. Baskys, A.; Malenka, R.C. Agonists at Metabotropic Glutamate Receptors Presynaptically Inhibit EPSCs in Neonatal Rat Hippocampus. J. Physiol. 1991, 444, 687-701.
17. Masu, M.; Tanabe, Y.; Tsuchida, K.; Shigemoto, R.; Nakanishi, S. Sequence and Expression of a Metabotropic Glutamate Receptor. Nature 1991, 349(6312), 760-765.
18. Houamed, K.M.; Kuijper, J.L.; Gilbert, T.L.; Haldeman, B.A.; O'Hara, P.J.; Mulvihill, E.R.; Almers, W.; Hagen, F.S. Cloning, Expression, and Gene Structure of a G Protein-Coupled Glutamate Receptor from Rat Brain. Science 1991, 252(5010), 1318-1321.
19. Pin, J.P.; Galvez, T.; Prezeau, L. Evolution, Structure, and Activation Mechanism of Family 3/C G-Protein-Coupled Receptors. Pharmacol. Ther. 2003, 98(3), 325-354.
20. Conn, P.J.; Pin, J.P. Pharmacology and Functions of Metabotropic Glutamate Receptors. Annu. Rev. Pharmacol. Toxicol. 1997, 37, 205-237.
21. Pin, J.P.; Acher, F. The Metabotropic Glutamate Receptors: Structure, Activation Mechanism and Pharmacology. Curr. Drug Targets CNS Neurol. Disord. 2002, 1(3), 297-317.
22. Schoepp, D.D.; Jane, D.E.; Monn, J.A. Pharmacological Agents Acting at Subtypes of Metabotropic Glutamate Receptors. Neuropharmacology 1999, 38(10), 1431-1476.
23. Anwyl, R. Metabotropic Glutamate Receptors: Electrophysiological Properties and Role in Plasticity. Brain. Res. Rev. 1999, 29(1), 83-120.
24. Ueda, Y.; Iwakabe, H.; Masu, M.; Suzuki, M.; Nakanishi, S. The mGluR6 5′ Upstream Transgene Sequence Directs a Cell-Specific and Developmentally Regulated Expression in Retinal Rod and on-Type Cone Bipolar Cells. J. Neurosci. 1997, 17(9), 3014-3023.
25. Schools, G.P.; Kimelberg, H.K. mGluR3 and mGluR5 Are the Predominant Metabotropic Glutamate Receptor mRNAs Expressed in Hippocampal Astrocytes Acutely Isolated from Young Rats. J. Neurosci. Res. 1999, 58(4), 533-543.
26. Gereau, R.W.T.; Conn, P.J. Multiple Presynaptic Metabotropic Glutamate Receptors Modulate Excitatory and Inhibitory Synaptic Transmission in Hippocampal Area Ca1. J. Neurosci. 1995, 15(10), 6879-6889.
27. Koulen, P.; Brandstatter, J.H. Pre- and Postsynaptic Sites of Action of mGluR8a in the Mammalian Retina. Invest. Ophthalmol. Vis. Sci. 2002, 43(6), 1933-1940.
28. Tamaru, Y.; Nomura, S.; Mizuno, N.; Shigemoto, R. Distribution of Metabotropic Glutamate Receptor mGluR3 in the Mouse CNS: Differential Location Relative to Pre- and Postsynaptic Sites. Neuroscience 2001, 106(3), 481-503.
29. Yamaguchi, S.; Nakanishi, S. Regional Expression and Regulation of Alternative Forms of mRNAs Derived from Two Distinct Transcription Initiation Sites of the Rat mGluR5 Gene. J. Neurochem 1998, 71(1), 60-68.
30. Tanabe, Y.; Masu, M.; Ishii, T.; Shigemoto, R.; Nakanishi, S. A Family of Metabotropic Glutamate Receptors. Neuron. 1992, 8(1), 169-179.
31. Pin, J.P.; Waeber, C.; Prezeau, L.; Bockaert, J.; Heinemann, S.F. Alternative Splicing Generates Metabotropic Glutamate Receptors Inducing Different Patterns of Calcium Release in Xenopus Oocytes. Proc. Natl. Acad. Sci. USA 1992, 89(21), 10331-10335.
32. Pin, J.P.; Duvoisin, R. The Metabotropic Glutamate Receptors: Structure and Functions. Neuropharmacology 1995, 34(1), 1-26.
33. Stephan, D.; Bon, C.; Holzwarth, J.A.; Galvan, M.; Pruss, R.M. Human Metabotropic Glutamate Receptor 1: mRNA Distribution, Chromosome Localization and Functional Expression of Two Splice Variants. Neuropharmacology 1996, 35(12), 1649-1660.
34. Lin, F.F.; Varney, M.; Sacaan, A.I.; Jachec, C.; Daggett L.P.; Rao, S.; Flor, P.; Kuhn, R.; Kerner, J.A.; Standaert, D.; Young, A.B.; Velicelebi, G. Cloning and Stable Expression of the mGluR1b Subtype of Human Metabotropic Receptors and Pharmacological Comparison with the mGluR5a Subtype. Neuropharmacology 1997, 36(7), 917-931.
35. Laurie, D.J.; Boddeke, H.W,; Hiltscher, R.; Sommer, B. HmGlu1d, a Novel Splice Variant of the Human Type I Metabotropic Glutamate Receptor. Eur. J. Pharmacol. 1996, 296(2), R1-R3.
36. Soloviev, M.M.; Ciruela, F.; Chan, W.Y.; McIlhinney, R.A. Identification, Cloning and Analysis of Expression of a New Alternatively Spliced Form of the Metabotropic Glutamate Receptor mGluR1 mRNA1. Biochim. Biophys. Acta 1999, 1446(1-2), 161-166.
37. Zhu, H.; Ryan, K.; Chen, S. Cloning of Novel Splice Variants of Mouse mGluR1. Brain. Res. Mol. Brain. Res. 1999, 73(1-2), 93-103.
38. Pickering, D.S.; Thomsen, C.; Suzdak, P.D.; Fletcher, E.J.; Robitaille, R.; Salter, M.W.; MacDonald, J.F.; Huang, X.P.; Hampson, D.R. A Comparison of Two Alternatively Spliced Forms of a Metabotropic Glutamate Receptor Coupled to Phosphoinositide Turnover. J. Neurochem. 1993, 61(1), 85-92.
39. Flor, P.J.; Gomeza, J.; Tones, M.A.; Kuhn, R.; Pin, J.P.; Knopfel, T. The C-Terminal Domain of the mGluR1 Metabotropic Glutamate Receptor Affects Sensitivity to Agonists. J. Neurochem. 1996, 67(1), 58-63.
40. Joly, C.; Gomeza, J.; Brabet, I.; Curry, K.; Bockaert, J.; Pin, J.P. Molecular, Functional, and Pharmacological Characterization of the Metabotropic Glutamate Receptor Type 5 Splice Variants: Comparison with mGluR1. J. Neurosci. 1995, 15(5 Pt 2), 3970-3981.
41. Prezeau, L.; Gomeza, J.; Ahern, S.; Mary, S.; Galvez, T.; Bockaert, J.; Pin, J.P. Changes in the Carboxyl-Terminal Domain of Metabotropic Glutamate Receptor 1 by Alternative Splicing Generate Receptors with Differing Agonist-Independent Activity. Mol. Pharmacol. 1996, 49(3), 422-429.
42. Hiltscher, R.; Seuwen, K.; Boddeke, H.W.; Sommer, B.; Laurie, D.J. Functional Coupling of Human Metabotropic Glutamate Receptor HmGlu1d: Comparison to Splice Variants HmGlu1a and - 1b. Neuropharmacology. 1998, 37(7), 827-837.
43. Chan, W.Y.; Soloviev, M.M.; Ciruela, F.; McIlhinney, R.A. Molecular Determinants of Metabotropic Glutamate Receptor 1b Trafficking. Mol. Cell Neurosci. 2001, 17(3), 577-588.
44. Fagni, L.; Ango, F.; Perroy, J.; Bockaert, J. Identification and Functional Roles of Metabotropic Glutamate Receptor-Interacting Proteins. Semin. Cell Dev. Biol. 2004, 15(3), 289-298.
45. Tu, J.C.; Xiao, B.; Yuan, J.P.; Lanahan, A.A.; Leoffert, K,; Li, M.; Linden, D.J.; Worley, P.F. Homer Binds a Novel Proline-Rich Motif and Links Group 1 Metabotropic Glutamate Receptors with IP3 Receptors. Neuron. 1998, 21(4), 717-726.
46. Xiao, B.; Tu, J.C.; Petralia, R.S.; Yuan, J.P.; Doan, A.; Breder, C.D.; Ruggiero, A.; Lanahan, A.A.; Wenthold, R.J.; Worley, P.F. Homer Regulates the Association of Group 1 Metabotropic Glutamate Receptors with Multivalent Complexes of Homer-Related, Synaptic Proteins. Neuron 1998, 21(4), 707-716.
47. Kammermeier, P.J.; Xiao, B.; Tu, J.C.; Worley, P.F.; Ikeda, S.R. Homer Proteins Regulate Coupling of Group I Metabotropic Glutamate Receptors to N-Type Calcium and M-Type Potassium Channels. J. Neurosci. 2000, 20(19), 7238-7245.
48. Brakeman, P.R.; Lanahan, A.A.; O'Brien, R.; Roche, K.; Barnes, C.A.; Huganir, R.L.; Worley, P.F. Homer: A Protein that Selectively Binds Metabotropic Glutamate Receptors. Nature 1997, 386(6622), 284-288.
49. Kato, A.; Ozawa, F.; Saitoh, Y.; Fukazawa, Y.; Sugiyama, H.; Inokuchi, K. Novel Members of the Vesl/Homer Family of PDZ Proteins that Bind Metabotropic Glutamate Receptors. J. Biol. Chem. 1998, 273(37), 23969-23975.
50. Ango, F.; Prezeau, L.; Muller, T.; Tu, J.C.; Xiao, B.; Worley, P.F.; Pin, J.P.; Bockaert, J.; Fagni, L. Agonist-Independent Activation of Metabotropic Glutamate Receptors by the Intracellular Protein Homer. Nature 2001, 411(6840), 962-965.
51. El Far, O.; Betz, H. G-Protein-Coupled Receptors for Neurotransmitter Amino Acids: C-Terminal Tails, Crowded Signalosomes. Biochem. J. 2002, 365(Pt 2), 329-336.
52. Boudin, H.; Doan, A.; Xia, J.; Shigemoto, R.; Huganir, R.L.; Worley, P.; Craig, A.M. Presynaptic Clustering of mGluR7a Requires the PICK1 PDZ Domain Binding Site. Neuron 2000, 28(2), 485-497.
53. El Far, O.; Airas, J.; Wischmeyer, E.; Nehring, R.B.; Karschin, A.; Betz, H. Interaction of the C-Terminal Tail Region of the Metabotropic Glutamate Receptor 7 with the Protein Kinase C Substrate PICK1. Eur. J. Neurosci. 2000, 12(12), 4215-4221.
54. Dev, K.K.; Nakajima, Y.; Kitano, J.; Braithwaite, S.P.; Henley, J.M.; Nakanishi, S. PICK1 Interacts with and Regulates PKC Phosphorylation of mGluR7. J. Neurosci. 2000, 20(19), 7252-7257.
55. Nakajima, Y.; Yamamoto, T.; Nakayama, T.; Nakanishi, S. A Relationship between Protein Kinase C Phosphorylation and Calmodulin Binding to the Metabotropic Glutamate Receptor Subtype 7. J. Biol. Chem. 1999, 274(39), 27573-27577.
56. O'Connor, V.; El Far, O.; Bofill-Cardona, E.; Nanoff, C.; Freissmuth, M.; Karschin, A.; Airas, J.M.; Betz, H.; Boehm, S. Calmodulin Dependence of Presynaptic Metabotropic Glutamate Receptor Signaling. Science 1999, 286(5442), 1180-1184.
57. Dev, K.K.; Nakanishi, S.; Henley, J.M. Regulation of mGlu(7) Receptors by Proteins That Interact with the Intracellular C-Terminus. Trends Pharmacol. Sci. 2001, 22(7), 355-361.
58. Sorensen, S.D.; Macek, T.A.; Cai, Z.; Saugstad, J.A.; Conn, P.J. Dissociation of Protein Kinase-Mediated Regulation of Metabotropic Glutamate Receptor 7 (mGluR7) Interactions with Calmodulin and Regulation of mGluR7 Function. Mol. Pharmacol. 2002, 61(6), 1303-1312.
59. Masugi, M.; Yokoi, M.; Shigemoto, R.; Muguruma, K.; Watanabe, Y.; Sansig, G.; van der Putten, H.; Nakanishi, S. Metabotropic Glutamate Receptor Subtype 7 Ablation Causes Deficit in Fear Response and Conditioned Taste Aversion. J. Neurosci. 1999, 19(3), 955-963.
60. Gerlai, R.; Henderson, J.T.; Roder, J.C.; Jia, Z. Multiple Behavioral Anomalies in GluR2 Mutant Mice Exhibiting Enhanced LTP. Behav. Brain. Res. 1998, 95(1), 37-45.
61. Gerlai, R.; Roder, J.C.; Hampson, D.R. Altered Spatial Learning and Memory in Mice Lacking the mGluR4 Subtype of Metabotropic Glutamate Receptor. Behav. Neurosci. 1998, 112(3), 525-532.
62. Gerlai, R.; Adams, B.; Fitch, T.; Chaney, S.; Baez, M. Performance Deficits of mGluR8 Knockout Mice in Learning Tasks: The Effects of Null Mutation and the Background Genotype. Neuropharmacology 2002, 43(2), 235-249.
63. Yokoi, M.; Kobayashi, K.; Manabe, T.; Takahashi, T.; Sakaguchi, I.; Katsuura, G.; Shigemoto, R.; Ohishi, H.; Nomura, S.; Nakamura, K.; Nakao, K.; Katsuki, M.; Nakanishi, S. Impairment of Hippocampal Mossy Fiber LTD in Mice Lacking mGluR2. Science 1996, 273(5275), 645-647.
64. Bushell, T.J.; Sansig, G.; Collett, V.J.; van der Putten, H.; Collingridge, G.L. Altered Short-Term Synaptic Plasticity in Mice Lacking the Metabotropic Glutamate Receptor mglu7. Scientific World Journal 2002, 2, 730-737.
65. Gubellini, P.; Saulle, E.; Centonze, D.; Costa, C.; Tropepi, D.; Bernardi, G.; Conquet, F.; Calabresi, P. Corticostriatal Ltp Requires Combined mGluR1 and mGluR5 Activation. Neuropharmacology 2003, 44(1), 8-16.
66. Gubellini, P.; Saulle, E.; Centonze, D.; Bonsi, P.; Pisani, A.; Bernardi, G.; Conquet, F.; Calabresi, P. Selective Involvement of mGlu1 Receptors in Corticostriatal Ltd. Neuropharmacology 2001, 40(7), 839-846.
67. Higgins, G.A.; Ballard, T.M.; Kew, J.N.; Richards, J.G.; Kemp, J.A.; Adam, G.; Woltering, T.; Nakanishi, S.; Mutel, V. Pharmacological Manipulation of mGlu2 Receptors Influences Cognitive Performance in the Rodent. Neuropharmacology 2004, 46(7), 907-917.
68. Holscher, C.; Schmid, S.; Pilz, P.K.; Sansig, G.; van der Putten, H.; Plappert, C.F. Lack of the Metabotropic Glutamate Receptor Subtype 7 Selectively Impairs Short-Term Working Memory but Not Long-Term Memory. Behav. Brain. Res. 2004, 154(2), 473-481.
69. Pekhletski, R.; Gerlai, R.; Overstreet, L.S.; Huang, X.P.; Agopyan, N.; Slater, N.T.; Abramow-Newerly, W.; Roder, J.C.; Hampson, D.R. Impaired Cerebellar Synaptic Plasticity and Motor Performance in Mice Lacking the mGluR4 Subtype of Metabotropic Glutamate Receptor. J. Neurosci. 1996, 16(20), 6364-6373.
70. Kinney, G.G.; O'Brien J,A.; Lemaire, W.; Burno, M.; Bickel, D.J.; Clements, M.K.; Chen, T.B.; Wisnoski, D.D.; Lindsley, C.W.; Tiller, P.R.; Smith, S.; Jacobson, M.A.; Sur, C.; Duggan, M.E.; Pettibone, D.J.; Conn, P.J.; Williams, D.L. A Novel Selective Positive Allosteric Modulator of Metabotropic Glutamate Receptor Subtype 5 (mGluR5) Has In Vivo Activity and Antipsychotic-Like Effects in Rat Behavioral Models. J. Pharmacol. Exp. Ther. 2004.
71. Snead, O.C., 3rd; Banerjee, P.K.; Burnham, M.; Hampson, D. Modulation of Absence Seizures by the GABA(a) Receptor: A Critical Role for Metabotropic Glutamate Receptor 4 (mGluR4). J. Neurosci. 2000, 20(16), 6218-6224.
72. Sansig, G.; Bushell, T.J.; Clarke, V.R.; Rozov, A.; Burnashev, N.; Portet, C.; Gasparini, F.; Schmutz, M.; Klebs, K.; Shigemoto, R.; Flor, P.J.; Kuhn, R.; Knoepfel, T.; Schroeder, M.; Hampson, D.R.; Collett, V.J.; Zhang, C.; Duvoisin, R.M.; Collingridge, G.L.; van Der Putten, H. Increased Seizure Susceptibility in Mice Lacking Metabotropic Glutamate Receptor 7. J. Neurosci. 2001, 21(22), 8734-8745.
73. Stoop, R.; Conquet, F.; Pralong, E. Determination of Group I Metabotropic Glutamate Receptor Subtypes Involved in the Frequency of Epileptiform Activity in Vitro Using mGluR1 and mGluR5 Mutant Mice. Neuropharmacology 2003, 44(2), 157-162.
74. Mao, L.; Conquet, F.; Wang, J.Q. Augmented Motor Activity and Reduced Striatal Preprodynorphin mRNA Induction in Response to Acute Amphetamine Administration in Metabotropic Glutamate Receptor 1 Knockout Mice. Neuroscience 2001, 106(2), 303-312.
75. Chiamulera, C.; Epping-Jordan, M.P.; Zocchi, A.; Marcon, C.; Cottiny, C.; Tacconi, S.; Corsi, M.; Orzi, F.; Conquet, F. Reinforcing and Locomotor Stimulant Effects of Cocaine Are Absent in mGluR5 Null Mutant Mice. Nat. Neurosci. 2001, 4(9), 873-874.
76. Blednov, Y.A.; Walker, D.; Osterndorf-Kahanek, E.; Harris, R.A. Mice Lacking Metabotropic Glutamate Receptor 4 Do Not Show the Motor Stimulatory Effect of Ethanol. Alcohol 2004, 34(2-3), 251-259.
77. Morishima, Y.; Miyakawa, T.; Furuyashiki, T.; Tanaka, Y.; Mizuma, H.; Nakanishi, S. Enhanced Cocaine Responsiveness and Impaired Motor Coordination in Metabotropic Glutamate Receptor Subtype 2 Knockout Mice. Proc. Natl. Acad. Sci. USA 2005, 102(11), 4170-4175.
78. Brody, S.A.; Conquet, F.; Geyer, M.A. Disruption of Prepulse Inhibition in Mice Lacking mGluR1. Eur. J. Neurosci. 2003, 18(12), 3361-3366.
79. Brody, S.A.; Conquet, F.; Geyer, M.A. Effect of Antipsychotic Treatment on the Prepulse Inhibition Deficit of mGluR5 Knockout Mice. Psychopharmacology (Berl). 2004, 172(2), 187-195.
80. Brody, S.A.; Dulawa, S.C.; Conquet, F.; Geyer, M.A. Assessment of a Prepulse Inhibition Deficit in a Mutant Mouse Lacking mGlu5 Receptors. Mol. Psychiatry 2004, 9(1), 35-41.
81. Sugihara, H.; Inoue, T.; Nakanishi, S.; Fukuda, Y. A Late on Response Remains in Visual Response of the mGluR6-Deficient Mouse. Neurosci. Lett. 1997, 233(2-3), 137-140.
82. Takao, M.; Morigiwa, K.; Sasaki, H.; Miyoshi, T.; Shima, T.; Nakanishi, S.; Nagai, K.; Fukuda, Y. Impaired Behavioral Suppression by Light in Metabotropic Glutamate Receptor Subtype 6-Deficient Mice. Neuroscience 2000, 97(4), 779-787.
83. Brodkin, J.; Bradbury, M.; Busse, C.; Warren, N.; Bristow, L.J.; Varney, M.A. Reduced Stress-Induced Hyperthermia in mGluR5 Knockout Mice. Eur. J. Neurosci. 2002, 16(11), 2241-2244.
84. Linden, A.M.; Johnson, B.G.; Peters, S.C.; Shannon, H.E.; Tian, M.; Wang, Y.; Yu, J.L.; Koster, A.; Baez, M.; Schoepp, D.D. Increased Anxiety-Related Behavior in Mice Deficient for Metabotropic Glutamate 8 (mGlu8) Receptor. Neuropharmacology 2002, 43(2), 251-259.
85. Linden, A.M.; Shannon, H.; Baez, M.; Yu, J.L.; Koester, A.; Schoepp, D.D. Anxiolytic-Like Activity of the mGlu2/3 Receptor Agonist LY354740 in the Elevated Plus Maze Test Is Disrupted in Metabotropic Glutamate Receptor 2 and 3 Knock-out Mice. Psychopharmacology (Berl). 2005, 179(1), 284-291.
86. Bradbury, M.J.; Campbell, U.; Giracello, D.; Chapman, D.; King, C.; Tehrani, L.; Cosford, N.D.; Anderson, J.; Varney, M.A.; Strack, A.M. Metabotropic Glutamate Receptor mGlu5 Is a Mediator of Appetite and Energy Balance in Rats and Mice. J. Pharmacol. Exp. Ther. 2005, 313(1), 395-402.
87. Gasparini, F.; Kuhn, R.; Pin, J.P. Allosteric Modulators of Group I Metabotropic Glutamate Receptors: Novel Subtype-Selective Ligands and Therapeutic Perspectives. Curr. Opin. Pharmacol. 2002, 2(1), 43-49.
88. Schoepp, D.D,; Johnson, B.G.; Wright, R.A.; Salhoff, C.R.; Mayne, N.G.; Wu, S.; Cockerman, S.L.; Burnett, J.P.; Belegaje, R.; Bleakman, D.; Monn, J.A. LY354740 Is a Potent and Highly Selective Group II Metabotropic Glutamate Receptor Agonist in Cells Expressing Human Glutamate Receptors. Neuropharmacology 1997, 36(1), 1-11.
89. Helton, D.R.; Tizzano, J.P.; Monn, J.A.; Schoepp, D.D.; Kallman, M.J. Anxiolytic and Side-Effect Profile of LY354740: A Potent, Highly Selective, Orally Active Agonist for Group II Metabotropic Glutamate Receptors. J. Pharmacol. Exp. Ther. 1998, 284(2), 651-660.
90. Monn, J.A.; Valli, M.J.; Massey, S.M.; Wright, R.A.; Salhoff, C.R.; Johnson, B.G.; Howe, T.; Alt, C.A.; Rhodes, G.A.; Robey, R.L.; Griffey, K.R.; Tizzano, J.P.; Kallman, M.J.; Helton, D.R.; Schoepp, D.D. Design, Synthesis, and Pharmacological Characterization of (+)-2-Aminobicyclo[3.1.0]Hexane-2,6-Dicarboxylic Acid (LY354740): A Potent, Selective, and Orally Active Group 2 Metabotropic Glutamate Receptor Agonist Possessing Anticonvulsant and Anxiolytic Properties. J. Med. Chem. 1997, 40(4), 528-537.
91. Swanson, C.J.; Bures, M.; Johnson, M.P.; Linden, A.M.; Monn, J.A.; Schoepp, D.D. Metabotropic Glutamate Receptors as Novel Targets for Anxiety and Stress Disorders. Nat. Rev. Drug Discov. 2005, 4(2), 131-144.
92. Cartmell, J.; Monn, J.A.; Schoepp, D.D. Attenuation of Specific Pcp-Evoked Behaviors by the Potent mGlu2/3 Receptor Agonist, LY379268 and Comparison with the Atypical Antipsychotic, Clozapine. Psychopharmacology (Berl). 2000, 148(4), 423-429.
93. Schoepp, D.D.; Wright, R.A.; Levine, L.R.; Gaydos, B.; Potter, W.Z. LY354740, an mGlu2/3 Receptor Agonist as a Novel Approach to Treat Anxiety/Stress. Stress. 2003, 6(3), 189-197.
94. Jones, C.K.; Eberle, E.L.; Peters, S.C.; Monn, J.A.; Shannon, H.E. Analgesic Effects of the Selective Group II (mGlu2/3) Metabotropic Glutamate Receptor Agonists LY379268 and LY389795 in Persistent and Inflammatory Pain Models after Acute and Repeated Dosing. Neuropharmacology 2005, In press.
95. Litschig, S.; Gasparini, F.; Rueegg, D.; Stoehr, N.; Flor, P.J.; Vranesic, I.; Prezeau, L.; Pin, J.P.; Thomsen, C.; Kuhn, R. CPCCOEt, a Noncompetitive Metabotropic Glutamate Receptor 1 Antagonist, Inhibits Receptor Signaling without Affecting Glutamate Binding. Mol. Pharmacol. 1999, 55(3), 453-461.
96. Annoura, H.; Fukunaga, A.; Uesugi, M.; Tatsuoka, T.; Horikawa, Y. A Novel Class of Antagonists for Metabotropic Glutamate Receptors, 7-(Hydroxyimino)Cyclopropa[B]Chromen1a-Carboxylates. Bioorg. Med. Chem. Lett. 1996, 6, 763-766.
97. Varney, M.A.; Cosford, N.D.; Jachec, C.; Rao, S.P.; Sacaan, A.; Lin, F.F.; Bleicher, L.; Santori, E.M.; Flor, P.J.; Allgeier, H.; Gasparini, F.; Kuhn, R.; Hess, S.D.; Velicelebi, G.; Johnson, E.C. SIB-1757 and SIB-1893: Selective, Noncompetitive Antagonists of Metabotropic Glutamate Receptor Type 5. J. Pharmacol. Exp. Ther. 1999, 290(1), 170-181.
98. Spooren, W.P.; Gasparini, F.; Salt, T.E.; Kuhn, R. Novel Allosteric Antagonists Shed Light on mGlu(5) Receptors and CNS Disorders. Trends Pharmacol. Sci. 2001, 22(7), 331-337.
99. Cosford, N.D.; Tehrani, L.; Roppe, J.; Schweiger, E.; Smith, N.D.; Anderson, J.; Bristow, L.; Brodkin, J.; Jiang, X.; McDonald, I.; Rao, S.; Washburn, M.; Varney, M.A. 3-[(2-Methyl-1,3-Thiazol-4-Y1) Ethynyl]-Pyridine: A Potent and Highly Selective Metabotropic Glutamate Subtype 5 Receptor Antagonist with Anxiolytic Activity. J. Med. Chem. 2003, 46(2), 204-206.
100. Gasparini, F.; Lingenhohl, K.; Stoehr, N.; Flor, P.J.; Heinrich, M.; Vranesic, I.; Biollaz, M.; Allgeier, H.; Heckendorn, R.; Urwyler, S.; Varney, M.A.; Johnson, E.C.; Hess, S.D.; Rao, S.P.; Sacaan, A.I.; Santori, E.M.; Velicelebi, G.; Kuhn, R. 2-Methyl-6-(Phenylethynyl)-Pyridine (MPEP), a Potent, Selective and Systemically Active mGlu5 Receptor Antagonist. Neuropharmacology 1999, 38(10), 1493-1503.
101. Spooren, W.P.; Vassout, A.; Neijt, H.C.; Kuhn, R.; Gasparini, F.; Roux, S.; Porsolt, R.D.; Gentsch, C. Anxiolytic-Like Effects of the Prototypical Metabotropic Glutamate Receptor 5 Antagonist 2-Methyl-6-(Phenylethynyl) Pyridine in Rodents. J. Pharmacol. Exp. Ther. 2000, 295(3), 1267-1275.
102. Tatarczynska, E.; Klodzinska, A.; Chojnacka- Wojcik, E.; Palucha, A.; Gasparini, F.; Kuhn, R.; Pilc, A. Potential Anxiolytic- and Antidepressant-Like Effects of MPEP, a Potent, Selective and Systemically Active mGlu5 Receptor Antagonist. Br. J. Pharmacol. 2001, 132(7), 1423-1430.
103. Brodkin, J.; Busse, C.; Sukoff, S.J.; Varney, M.A. Anxiolytic-Like Activity of the mGluR5 Antagonist MPEP a Comparison with Diazepam and Buspirone. Pharmacol. Biochem. Behav. 2002, 73(2), 359-366.
104. Varty, G.B.; Grilli, M.; Forlani, A.; Fredduzzi, S.; Grzelak, M.E.; Guthrie, D.H.; Hodgson, R.A.; Lu, S.X.; Nicolussi, E.; Pond, A.J.; Parker, E.M.; Hunter, J.C.; Higgins, G.A.; Reggiani, A.; Bertorelli, R. The Antinociceptive and Anxiolytic-Like Effects of the Metabotropic Glutamate Receptor 5 (mGluR5) Antagonists, MPEP and MTEP, and the mGluR1 Antagonist LY456236, in Rodents: A Comparison of Efficacy and Side-Effect Profiles. Psychopharmacology (Berl). 2005, 179(1), 207-217.
105. Busse, C.S.; Brodkin, J.; Tattersall, D.; Anderson, J.J.; Warren, N.; Tehrani, L.; Bristow, L.J.; Varney, M.A.; Cosford, N.D. The Behavioral Profile of the Potent and Selective mGlu5 Receptor Antagonist 3-[(2-Methyl-1,3-Thiazol-4-Y1)Ethynyl]Pyridine (MTEP) in Rodent Models of Anxiety. Neuropsychopharmacology 2004, 29(11), 1971-1979.
106. Ossowska, K.; Konieczny, J.; Wolfarth, S.; Wieronska, J.; Pilc, A. Blockade of the Metabotropic Glutamate Receptor Subtype 5 (mGluR5) Produces Antiparkinsonian-Like Effects in Rats. Neuropharmacology 2001, 41(4), 413-420.
107. Breysse, N.; Baunez, C.; Spooren, W.; Gasparini, F.; Amalric, M. Chronic but Not Acute Treatment with a Metabotropic Glutamate 5 Receptor Antagonist Reverses the Akinetic Deficits in a Rat Model of Parkinsonism. J. Neurosci. 2002, 22(13), 5669-5678.
108. Ossowska, K.; Konieczny, J.; Wolfarth, S.; Pilc, A. MTEP, a New Selective Antagonist of the Metabotropic Glutamate Receptor Subtype 5 (mGluR5), Produces Antiparkinsonian-Like Effects in Rats. Neuropharmacology 2005.
109. Pilc, A.; Klodzinska, A.; Branski, P.; Nowak, G.; Palucha, A.; Szewczyk, B.; Tatarczynska, E.; Chojnacka-Wojcik, E.; Wieronska, J.M. Multiple MPEP Administrations Evoke Anxiolytic- and Antidepressant-Like Effects in Rats. Neuropharmacology 2002, 43(2), 181-187.
110. Wieronska, J.M.; Szewczyk, B.; Branski, P.; Palucha, A.; Pilc, A. Antidepressant-Like Effect of MPEP, a Potent, Selective and Systemically Active Mglu5 Receptor Antagonist in the Olfactory Bulbectomized Rats. Amino Acids 2002, 23(1-3), 213-216.
111. Johnson, M.P.; Nisenbaum, T.H.; Emkey, R.; Baez, M.; Kingston, A.E. Allosteric Modulators of Metabotropic Glutamate Receptors: Lessons Learnt from mGlu1, mGlu2, and mGlu5 Potentiators and Antagonists. Biochem. Soc. Trans. 2004, 32, 881-887.
112. Knoflach, F.; Mutel, V.; Jolidon, S.; Kew, J.N.; Malherbe, P.; Vieira, E.; Wichmann, J.; Kemp, J.A. Positive Allosteric Modulators of Metabotropic Glutamate 1 Receptor: Characterization, Mechanism of Action, and Binding Site. Proc. Natl. Acad. Sci. USA 2001, 98(23), 13402-13407.
113. Pagano, A.; Ruegg, D.; Litschig, S.; Stoehr, N.; Stierlin, C.; Heinrich, M.; Floersheim, P.; Prezeau, L.; Carroll, F.; Pin, J.P.; Cambria, A.; Vranesic, I.; Flor, P.J.; Gasparini, F.; Kuhn, R. The Non-Competitive Antagonists 2-Methyl-6-(Phenylethynyl)Pyridine and 7-Hydroxyiminocyclopropan[B]Chromen-1a-Carboxylic Acid Ethyl Ester Interact with Overlapping Binding Pockets in the Transmembrane Region of Group I Metabotropic Glutamate Receptors. J. Biol. Chem. 2000, 275(43), 33750-33758.
114. Mohler, H.; Fritschy, J.M.; Rudolph, U. A New Benzodiazepine Pharmacology. J. Pharmacol. Exp. Ther. 2002, 300(1), 2-8.
115. Johnson, M.P.; Baez, M.; Jagdmann, G.E. Jr.; Britton, T.C.; Large, T.H.; Callagaro, D.O.; Tizzano, J.P.; Monn, J.A.; Schoepp, D.D. Discovery of Allosteric Potentiators for the Metabotropic Glutamate 2 Receptor: Synthesis and Subtype Selectivity of N-(4-(2-Methoxyphenoxy)Phenyl)-N-(2,2,2- Trifluoroethylsulfonyl) Pyrid-3-Ylmethylamine. J. Med. Chem. 2003, 46(15), 3189-3192.
116. Barda, D.A.; Wang, Z.Q.; Britton, T.C.; Henry, S.S.; Jagdmann, G.E.; Coleman, D.S.; Johnson, M.P.; Andis, S.L.; Schoepp, D.D. SAR Study of a Subtype Selective Allosteric Potentiator of Metabotropic Glutamate 2 Receptor, N-(4-Phenoxyphenyl)-N-(3-Pyridinylmethyl) Ethanesulfonamide. Bioorg. Med. Chem. Lett. 2004, 14(12), 3099-3102.
117. Pinkerton, A.B.; Cube, R.V.; Hutchinson, J.H.; James, J.K.; Gardner, M.F.; Schaffhauser, H.; Rowe, B.A.; Daggett, L.P.; Vernier, J.M. Allosteric Potentiators of the Metabotropic Glutamate Receptor 2 (mGlu2). Part 2: 4-Thiopyridyl Acetophenones as Non-Tetrazole Containing Mglu2 Receptor Potentiators. Bioorg. Med. Chem. Lett. 2004, 14(23), 5867-5872.
118. Pinkerton, A.B.; Cube, R.V.; Hutchinson, J.H.; Rowe, B.A.; Schaffhauser, H.; Zhao, X.; Daggett, L.P.; Vernier, J.M. Allosteric Potentiators of the Metabotropic Glutamate Receptor 2 (mGlu2). Part 1: Identification and Synthesis of Phenyl-Tetrazolyl Acetophenones. Bioorg. Med. Chem. Lett. 2004, 14(21), 5329-5332.
119. Pinkerton, A.B.; Vernier, J.M.; Schaffhauser, H.; Rowe, B.A.; Campbell, U.C.; Rodriguez, D.E.; Lorrain, D.S.; Baccei, C.S.; Daggett, L.P.; Bristow, L.J. Phenyl-Tetrazolyl Acetophenones: Discovery of Positive Allosteric Potentiatiors for the Metabotropic Glutamate 2 Receptor. J. Med. Chem. 2004, 47(18), 4595-4599.
120. Schaffhauser, H.; Rowe, B.A.; Morales, S.; Chavez-Noriega, L.E.; Yin, R.; Jachec, C.; Rao, S.P.; Bain, G.; Pinkerton, A.B.; Vernier, J.M.; Bristow, L.J.; Varney, M.A.; Daggett, L.P. Pharmacological Characterization and Identification of Amino Acids Involved in the Positive Modulation of Metabotropic Glutamate Receptor Subtype 2. Mol. Pharmacol. 2003, 64(4), 798-810.
121. Johnson, M.P.; Chamberlain, M. Modulation of Stress-Induced and Stimulated Hyperprolactinemia with the Group II Metabotropic Glutamate Receptor Selective Agonist, LY379268. Neuropharmacology 2002, 43(5), 799-808.
122. Johnson, M.P.; Barda, D.; Britton, T.C.; Emkey, R.; Hornback, W.J.; Jagdmann, G.E.; McKinzie, D.L.; Nisenbaum, E.S.; Tizzano, J.P.; Schoepp, D.D. Metabotropic Glutamate 2 Receptor Potentiators: Receptor Modulation, Frequency-Dependent Synaptic Activity, and Efficacy in Preclinical Anxiety and Psychosis Model(s). Psychopharmacology 2005, 179(1), 271-283.
123. Marino, M.J.; Conn, J.P. Modulation of the Basal Ganglia by Metabotropic Glutamate Receptors: Potential for Novel Therapeutics. Curr. Drug Target CNS Neurol. Disord. 2002, 1(3), 239-250.
124. Valenti, O.; Marino, M.J.; Conn, P.J. Modulation of Excitatory Transmission onto Midbrain Dopaminergic Neurons of the Rat by Activation of Group III Metabotropic Glutamate Receptors. Ann. N.Y. Acad. Sci. 2003, 1003, 479-480.
125. Maj, M.; Bruno, V.; Dragic, Z.; Yamamoto, R.; Battaglia, G.; Inderbitzin, W.; Stoehr, N.; Stein, T.; Gasparini, F.; Vranesic, I.; Kuhn, R.; Nicoletti, F.; Flor, P.J. (-)-PHCCC, a Positive Allosteric Modulator of mGluR4: Characterization, Mechanism of Action, and Neuroprotection. Neuropharmacology 2003, 45(7), 895-906.
126. Marino, M.J.; Williams, D.L., Jr.; O'Brien, J.A.; Valenti, O.; McDonald, T.P.; Clements, M.K.; Wang, R.; DiLella, A.G.; Hess, J.F.; Kinney, G.G.; Conn, P.J. Allosteric Modulation of Group III Metabotropic Glutamate Receptor 4: A Potential Approach to Parkinson's Disease Treatment. Proc. Natl. Acad. Sci. USA 2003, 100(23), 13668-13673.
127. O'Brien, J.A.; Lemaire, W.; Chen, T.B.; Chang, R.S.; Jacobson, M.A.; Ha, S.N.; Lindsley, C.W.; Schaffhauser, H.J.; Sur, C.; Pettibone, D.J.; Conn, P.J.; Williams, D.L. Jr. A Family of Highly Selective Allosteric Modulators of the Metabotropic Glutamate Receptor Subtype 5. Mol. Pharmacol. 2003, 64(3), 731-740.
128. O'Brien, J.A.; Lemaire, W.; Wittmann, M.; Jacobson, M.A.; Ha, S.N.; Wisnoski, D.D.; Lindsley, C.W.; Schaffhauser, H.J.; Rowe, B.; Sur, C.; Duggan, M.E.; Pettibone, D.J.; Conn, P.J.; Williams, D.L. Jr. A Novel Selective Allosteric Modulator Potentiates the Activity of Native Metabotropic Glutamate Receptor Subtype 5 in Rat Forebrain. J. Pharmacol. Exp. Ther. 2004, 309(2), 568-577.
129. Kinney, G.G.; O'Brien, J.A.; Lemaire, W.; Burno, M.; Bickel, D.J.; Clements, M.K.; Chen, T.B.; Wisnoski, D.D.; Lindsley, C.W.; Tiller, P.R.; Smith, S.; Jacobson, M.A.; Sur, C.; Duggan, M.E.; Pettibone, D.J.; Conn, P.J.; Williams, D.L. Jr. A Novel Selective Positive Allosteric Modulator of Metabotropic Glutamate Receptor Subtype 5 Has in Vivo Activity and Antipsychotic-Like Effects in Rat Behavioral Models. J. Pharmacol. Exp. Ther. 2005, 313(1), 199-206.
130. Lindsley, C.W.; Wisnoski, D.D.; Leister, W.H.; O'Brien, J.A.; Lemaire, W.; Williams, D.L.; Burno, M.; Sur, C.; Kinney, G.G.; Pettibone, D.J.; Tiller, P.R.; Smith, S.; Duggan, M.E.; Hartman, G.D.; Conn, P.J.; Huff, J.R. Discovery of Positive Allosteric Modulators for the Metabotropic Glutamate Receptor Subtype 5 (mGluR5) from a Series of N-(1,3-diphenyl-1H-prazol-5-yl) Benzamides that Potentiate Receptor Function in Vivo. J. Med. Chem. 2004, 47: 5825-5828.